AbbVie IncNYSE:ABBV
- LAST PRICE160.0797
- TODAY'S CHANGE (%)-1.2003 (-0.7442%)
- Bid / Lots160.0600/ 2
- Ask / Lots160.1100/ 2
- Open / Previous Close161.6500 / 161.2800
- Day Range
- 52 Week Range
- Volume1,228,291
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ABBV |
|---|---|---|
| 09:32 ET | 77785 | 161.96 |
| 09:34 ET | 6671 | 162.18 |
| 09:36 ET | 6767 | 161.455 |
| 09:38 ET | 5546 | 161.36 |
| 09:39 ET | 5586 | 161.38 |
| 09:41 ET | 11501 | 161.19 |
| 09:43 ET | 3960 | 161.225 |
| 09:45 ET | 3807 | 161.13 |
| 09:48 ET | 6028 | 161.25 |
| 09:50 ET | 4593 | 161.195 |
| 09:52 ET | 5247 | 161.36 |
| 09:54 ET | 4775 | 161.28 |
| 09:56 ET | 2270 | 161.19 |
| 09:57 ET | 6924 | 161.17 |
| 09:59 ET | 8356 | 161.15 |
| 10:01 ET | 11434 | 161.37 |
| 10:03 ET | 4660 | 161.675 |
| 10:06 ET | 12383 | 161.345 |
| 10:08 ET | 5352 | 161.32 |
| 10:10 ET | 4133 | 161.15 |
| 10:12 ET | 9909 | 161.06 |
| 10:14 ET | 6135 | 161.1 |
| 10:15 ET | 6847 | 160.99 |
| 10:17 ET | 6206 | 160.8399 |
| 10:19 ET | 5082 | 160.74 |
| 10:21 ET | 5273 | 160.52 |
| 10:24 ET | 11039 | 160.36 |
| 10:26 ET | 10769 | 160.5 |
| 10:28 ET | 5001 | 160.465 |
| 10:30 ET | 4293 | 160.425 |
| 10:32 ET | 9555 | 160.61 |
| 10:33 ET | 7546 | 160.685 |
| 10:35 ET | 8690 | 160.78 |
| 10:37 ET | 6413 | 160.705 |
| 10:39 ET | 34020 | 160.64 |
| 10:42 ET | 10385 | 160.67 |
| 10:44 ET | 11616 | 160.79 |
| 10:46 ET | 8700 | 160.86 |
| 10:48 ET | 7852 | 160.87 |
| 10:50 ET | 25382 | 160.96 |
| 10:51 ET | 9326 | 161.0804 |
| 10:53 ET | 21627 | 160.8975 |
| 10:55 ET | 15972 | 160.87 |
| 10:57 ET | 42767 | 161.03 |
| 11:00 ET | 10366 | 161.07 |
| 11:02 ET | 12842 | 160.98 |
| 11:04 ET | 9565 | 160.885 |
| 11:06 ET | 3717 | 160.87 |
| 11:08 ET | 27297 | 160.83 |
| 11:09 ET | 8284 | 160.87 |
| 11:11 ET | 8498 | 160.9015 |
| 11:13 ET | 9394 | 160.955 |
| 11:15 ET | 4018 | 161.03 |
| 11:18 ET | 10702 | 160.97 |
| 11:20 ET | 4910 | 160.94 |
| 11:22 ET | 8114 | 160.82 |
| 11:24 ET | 8844 | 160.79 |
| 11:26 ET | 8411 | 160.76 |
| 11:27 ET | 6291 | 160.71 |
| 11:29 ET | 6486 | 160.81 |
| 11:31 ET | 5994 | 160.73 |
| 11:33 ET | 8354 | 160.82 |
| 11:36 ET | 14201 | 160.635 |
| 11:38 ET | 3923 | 160.38 |
| 11:40 ET | 5501 | 160.4299 |
| 11:42 ET | 5631 | 160.39 |
| 11:44 ET | 6083 | 160.35 |
| 11:45 ET | 3993 | 160.4472 |
| 11:47 ET | 5033 | 160.41 |
| 11:49 ET | 4320 | 160.45 |
| 11:51 ET | 3725 | 160.37 |
| 11:54 ET | 3484 | 160.3215 |
| 11:56 ET | 2616 | 160.38 |
| 11:58 ET | 3919 | 160.3914 |
| 12:00 ET | 4910 | 160.46 |
| 12:02 ET | 5162 | 160.38 |
| 12:03 ET | 2301 | 160.4 |
| 12:05 ET | 10468 | 160.14 |
| 12:07 ET | 8246 | 160.105 |
| 12:09 ET | 8870 | 160.11 |
| 12:12 ET | 8799 | 160.12 |
| 12:14 ET | 7221 | 160.09 |
| 12:16 ET | 11113 | 160.131 |
| 12:18 ET | 4377 | 160.11 |
| 12:20 ET | 3163 | 160.07 |
| 12:21 ET | 2983 | 160.06 |
| 12:23 ET | 3424 | 160.17 |
| 12:25 ET | 7004 | 160.17 |
| 12:27 ET | 2802 | 160.21 |
| 12:30 ET | 5697 | 160.07 |
| 12:32 ET | 4215 | 160.11 |
| 12:34 ET | 8114 | 160.0797 |
Yesterday
May 8, 2024
QULIPTA (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults, from 8:00AM ET on Wednesday May 08, 2024 by Dow Jones
8:00AM ET on Wednesday May 08, 2024 by Dow Jones
May 7, 2024
DJ Teva Earnings Are Soon. What Could Keep the Stock Gains Going. -- Barrons.com, from 4:30PM ET on Tuesday May 07, 2024 by Dow Jones
4:30PM ET on Tuesday May 07, 2024 by Dow Jones
May 6, 2024
AbbVie to Present at the Bank of America Securities Healthcare Conference, from 8:00AM ET on Monday May 06, 2024 by Dow Jones
8:00AM ET on Monday May 06, 2024 by Dow Jones
Apr 29, 2024
DJ AbbVie Is Maintained at Overweight by Barclays, from 11:36AM ET on Monday Apr 29, 2024 by Dow Jones
11:36AM ET on Monday Apr 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
AbbVie Inc | 284.8B | 47.7x | -6.05% |
Merck & Co Inc | 327.5B | 143.7x | -43.23% |
AstraZeneca PLC | 239.1B | 38.0x | +17.52% |
Novartis AG | 224.9B | 23.4x | -5.59% |
Pfizer Inc | 161.0B | -464.1x | -7.10% |
Roche Holding AG | 205.9B | 15.7x | +3.28% |
Company Information
AbbVie Inc. is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica, Venclexta/Venclyxto, Epkinly and Elahere; aesthetics products, which include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, which include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy and Qulipta; eye care products, which consists of Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis and Other eye care, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies and independent retailers.
Contact Information
- Headquarters
- 1 N Waukegan RdNORTH CHICAGO, IL, United States 60064
- Phone
- 847-932-7900
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Richard Gonzalez
- Chief Executive Officer, Director
- Robert Michael
- Chief Financial Officer, Executive Vice President
- Scott Reents
- Chief Human Resource Officer, Executive Vice President
- Timothy Richmond
- Executive Vice President, General Counsel, Company Secretary
- Perry Siatis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $284.8B |
|---|---|
Revenue (TTM) | $54.4B |
Shares Outstanding | 1.8B |
Dividend Yield | 3.87% |
Annual Dividend Rate | 6.2000 USD |
Ex-Dividend Date | 04-12-24 |
Pay Date | 05-15-24 |
Beta | 0.59 |
EPS | $3.36 |
Book Value | $5.87 |
P/E Ratio | 47.7x |
Price/Sales (TTM) | 5.2 |
Price/Cash Flow (TTM) | 19.4x |
Operating Margin | 23.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
